Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.84
+0.08 (0.82%)
At close: Jun 26, 2026, 4:00 PM EDT
9.88
+0.04 (0.41%)
After-hours: Jun 26, 2026, 7:00 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year.
Employees
325
Change (1Y)
51
Growth (1Y)
18.61%
Revenue / Employee
$160,117
Profits / Employee
-$893,840
Market Cap
2.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Intellia Therapeutics | 377 |
| Nurix Therapeutics | 317 |
| Biohaven | 274 |
| Immunome | 206 |
| Kodiak Sciences | 130 |
OCUL News
- 5 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Ocular Therapeutix price target raised to $25 from $21 at H.C. Wainwright - TheFly
- 9 days ago - Ocular Therapeutix price target raised to $30 from $24 at Baird - TheFly
- 10 days ago - Ocular Therapeutix Transcript: Investor Day 2026 - Transcripts
- 10 days ago - Ocular Therapeutix Press release: FY 2026 - Filings
- 10 days ago - Ocular Therapeutix Slides: FY 2026 - Filings
- 10 days ago - Ocular Therapeutix trading resumes - TheFly
- 10 days ago - Ocular Therapeutix Investor Day to highlight FDA alignment on Axpaxli NDA - TheFly